<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Quarterly Report Under Section 13 or 15 (d)
of the Securities Exchange Act of 1934
10Q/A
For Quarter Ended: September 30, 1995
Commission File Number 0-14983
APPLIED MICROBIOLOGY, INC.
- --------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
New York 11-2653613
- --------------------------------------------------------------------------------
(State or other jurisdiction of (IRS Employer Identification Number)
incorporation of organization)
771 Old Saw Mill River Road, Tarrytown, New York 10591
- --------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
(914) 347-5767
- --------------------------------------------------------------------------------
(Registrant's telephone number, including area code)
- --------------------------------------------------------------------------------
(Former name, former address and former fiscal year, if changed since last
report)
Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports) and (2) has been subject to such filing
requirements for the past 90 days.
YES X NO ____
Indicate the number of shares outstanding of each of the issuer's classes of
common stock, as of the latest practicable date.
Common Stock, Par Value $.005 18,204,682 shares as of September 30, 1995
- ----------------------------- ------------------------------------------
<PAGE>
APPLIED MICROBIOLOGY, INC. AND SUBSIDIARY
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
APPLIED MICROBIOLOGY, INC.
--------------------------
Registrant
Date: November 22, 1995 By: /s/ Fredric D. Price
------------------------ ----------------------------------
Fredric D. Price
President, Chief Executive Officer,
and Director (Principal Accounting
and Financial Officer)
<PAGE>
APPLIED MICROBIOLOGY, INC. AND SUBSIDIARY
EXHIBIT INDEX
Exhibit
No. Description
------- -----------------------
27 Financial Data Schedule
<TABLE> <S> <C>
<ARTICLE> 5
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> JUN-30-1996
<PERIOD-END> SEP-30-1995
<CASH> 3,690
<SECURITIES> 0
<RECEIVABLES> 1,396
<ALLOWANCES> 14
<INVENTORY> 2,922
<CURRENT-ASSETS> 9,397
<PP&E> 7,759
<DEPRECIATION> 4,173
<TOTAL-ASSETS> 13,958
<CURRENT-LIABILITIES> 3,391
<BONDS> 728
<COMMON> 91
1,500
0
<OTHER-SE> 7,885
<TOTAL-LIABILITY-AND-EQUITY> 13,958
<SALES> 2,201
<TOTAL-REVENUES> 2,251
<CGS> 1,149
<TOTAL-COSTS> 3,330
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 26
<INCOME-PRETAX> (1,085)
<INCOME-TAX> 11
<INCOME-CONTINUING> (1,096)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (1,096)
<EPS-PRIMARY> (.06)
<EPS-DILUTED> (.06)
</TABLE>
